ReviewCVIR endovascular2026
Application of radiomics in abdominal aortic aneurysm and endovascular aneurysm repair-related adverse events imaging: a systematic review.
Review in CVIR endovascular, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAbdominal aortic aneurysm (AAA) carries high morbidity and mortality, while adverse events (AE) after endovascular aneurysm repair (EVAR) remain a major challenge. Accurate risk stratification is essential. Radiomics, by extracting quantitative imaging features, offers a noninvasive approach that may improve prediction of AAA outcomes and EVAR-related AE beyond conventional imaging. MAIN BODY: A search was conducted across Medline, Scopus, Embase, and Web of Science databases for articles published up to February 2024 to evaluate the application of radiomics in predicting the outcomes of AAA and diagnosing or predicting the AE related to EVAR. Inclusion criteria concentrated on observational studies that utilized a radiomics model based on the radiomic features extracted from imaging modalities to predict AAA outcomes and predict or diagnose EVAR-related AE. Eight studies involving 1729 observations met the inclusion criteria out of the 371 records yielded from the databases. Radiomics achieved a high area under the receiver operating characteristic (ROC) curve (AUROC) for predicting EVAR-related AE in three studies (up to 0.95), and it showed predictive value for AAA growth in three studies (AUROC 0.79-0.93) and rupture or repair in one study (AUROC 0.75). One study highlighted the diagnostic value of radiomics in post-EVAR endoleak detection using unenhanced computed tomography images (AUROC 0.91).
conclusionRadiomics showed promising but preliminary results in predicting AAA outcomes and EVAR-related AE, providing a noninvasive tool for risk assessment. However, further research with larger cohorts and external validation of the radiomics models is essential to confirm its clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.